The global medical robotics market, valued at USD 11.2 billion in 2025, is projected to reach USD 12.3 billion in 2026 and USD 31.3 billion by 2035, with a 4.5% CAGR during the forecast period 2026 to 2035. In terms of type of medical robot, the surgical robots segment holds the highest share (50%) of the market. Based on the deployment model, the on-premises hold the largest market share (nearly 90%). North America captures the majority of the market share, and Asia-Pacific is likely to grow...

The global agricultural biologicals market, valued at USD 3,571 million in 2025, is projected to reach USD 3,882 million in 2026 and USD 7,011 million by 2035, with a 6.8% CAGR during the forecast period 2026 to 2035. In terms of type of device, the neurothrombectomy device segment holds the highest share (~50%) of the market. With regards to therapeutic application, the ischemic stroke segment dominates the global market with more than 45% market share. North America captures the majority of...

The companion diagnostics (CDx) development market, valued at USD 892 million in 2025, is projected to reach USD 779 million in 2026 and USD 1,796 million by 2035, with a 9.7% CAGR during the forecast period 2026 to 2035. The introduction of companion diagnostics has revolutionized healthcare practices and led to a paradigm shift from the conventional, one-drug-for-all treatment to patient-centric personalized treatment. Till date, close to 170 companion diagnostics have been approved by the USF...

The coronary drug eluting stent market, valued at USD 4.04 billion in 2025, is projected to reach USD 4.50 billion in 2026 and USD 9.38 billion by 2035, with a 8.51% CAGR during the forecast period 2026 to 2035. According to the WHO, around one third of the annual global deaths (an estimated 18 million) can be attributed to cardiac disorders. In fact, in 2020 (post the onset of the pandemic), a more than 3% increase in the deaths related to heart diseases was reported. Notably, cardiac stents ar...

The telerehabilitation systems market is estimated to grow from USD 608.21 million in 2024 to reach USD 710.52 million in 2025 and USD 2,542.13 million by 2035, representing a higher CAGR of 13.6% during the forecast period. The telerehabilitation systems market analysis also features the likely distribution of the current and forecasted opportunity within the nutraceutical testing services domain across various segments, such as type of product, type of therapy, type of service, application are...

The global single-use consumables market, valued at USD 3.42 billion in 2024, is projected to reach USD 4.02 billion in 2025 and USD 15.19 billion by 2035, representing a CAGR of 14.2% during the forecast period. The global market is categorized across different types of materials, such as metals, plastics, glass, biodegradable materials and other materials. Currently, plastics segment holds the highest share (65%) of the market. Based on the end user, the global market is segmented into biophar...

The global drug screening market, valued at USD 8.53 billion in 2024, is projected to reach USD 10.2 billion in 2025 and USD 37.31 billion by 2035, representing a CAGR of 14.1% during the forecast period. One of the key objectives of the drug screening market report was to estimate the current size, opportunity, and the market growth potential, over the forecast period, till 2035. According to the drug screening market analysis, presently the product segment holds more than 55% of the market sha...

North America in vitro diagnostics market, valued at USD 42 billion in 2024, is estimated to reach USD 44 billion in 2025 and USD 75 billion by 2035, representing a CAGR of 5.5% during the forecast period.

The bone cement delivery system market, valued at USD 383 million in 2025, is projected to reach USD 407 million in 2026 and USD 501 billion by 2030, with a 7.0% CAGR during the forecast period 2026 to 2030. According to a study conducted by the International Osteoporosis Foundation (IOF), more than 200 million individuals around the world suffer from osteoporosis. In fact, the annual socioeconomic burden associated with this condition is estimated to be around USD 19 billion and EUR 37 billion,...

Europe in vitro diagnostics market, valued at USD 32 billion in 2024, is estimated to reach USD 34 billion in 2025 and USD 57 billion by 2035, representing a CAGR of 5.4% during the forecast period.

Asia Pacific in vitro diagnostics market, valued at USD 18 billion in 2024, is estimated to reach USD 19 billion in 2025 and USD 33 billion by 2035, representing a CAGR of 5.6% during the forecast period. On the basis of types of products, the Asia Pacific IVD market is distributed into instruments, reagents, and others. In Asia Pacific, the rising concern of chronic diseases such as diabetes, cardiovascular diseases, and infectious diseases necessitates developing in vitro diagnostics tests. Th...

The rise in dental tourism and medical aesthetic procedures further bolsters this demand. Industrial players, such as Straumann (Switzerland), Dentsply Sirona (US), ZimVie (US), and Osstem Implant (South Korea), actively launching new products and integrating comprehensive technologies to strengthen their market positions.For instance, in May 2025, Dr. Anurag Kashyap launched a state-of-the-art technique, the syncrystallization intra-oral welder, at RS Cosmetic & Dental Implant Centre, India. Th...

The global cold plasma market, valued at USD 2.43 billion in 2024, is projected to reach USD 2.82 billion in 2025 and USD 9.39 billion by 2035, representing a CAGR of 12.8% during the forecast period. Currently, the atmospheric pressure cold plasma segment accounts for 71% of the overall cold plasma market share. Among these, wound healing segment currently holds the highest cold plasma market share (33%). According to our cold plasma market report, currently the hospital sub segment accounts f...

It is worth noting that high pressure homogenization machinery also plays a significant role in cell lysis, and extraction to extract components like enzymes and proteins, which are used to make therapeutic drugs. Additionally, homogenizers aid in the development of nanoparticles formulation that are widely used as drug delivery system to enhance drug absorbency in the body.Notably, the benefits offered by high-shear homogenizers, the pharmaceutical industry is increasingly utilizing this machin...

Considering the increasing demand, market players are actively undertaking initiatives to encourage technological innovations in this field. For instance, in June 2025, Cosmo Pharmaceutical (Ireland) unveils its first-of-its-kind case study of its medical device software application which is connected with Medtronic GI Genius™ intelligent endoscopy module (an AI-powered platform for gastrointestinal endoscopy), with Apple Vision Pro. Similar to Cosmo Pharmaceutical (Ireland), various market pl...

It is worth noting that several researchers are currently conducting clinical studies on biodegradable devices, smart ingestible pills, biosensors and smart technology that helps to proactive disease management with real-time data monitoring. In addition, the market players are focusing on biodegradable material innovations, leveraging 3D printing and nanotechnology to create a synergistic ecosystem where monitoring, diagnosing and treatment can be done continually. The ongoing clinical need and...

The global virtual health services market is expected to be valued at USD 86.40 billion in 2025 and is expected to reach USD 1,077.21 billion by 2035. It is important to highlight here that the key players of industries are forging several partnership agreements which is likely to propel technological innovations in this industry. For instance, in September 2024, Hackensack Meridian Health partnered with K Health to launch a new 24 / 7 virtual primary care service aiming to offer east access to...

several industrial players have shown active interest in the field for technological innovations and product launch. For instance, in February 2025, Dr. Ronnapee Chaichawarat (profession of International School of Engineering, Chulalongkorn University, Thailand) launched exoskeleton wheelchair, a robotic suit specifically designed to help people with disabilities sit, stand and walk. Owing to the ongoing innovations, and rising incidence of neurological conditions, we believe that wheelchair mou...

The integration of AI technology with advanced diagnostic solutions helps in early sepsis detection with higher accuracy rate. Recently, investigators at Johns Hopkins University developed a Targeted Real-Time Early Warning System (TREWS) that features machine learning and AI technology for sepsis detection. This system has been used for two years in five different hospitals. Moreover, this system was used to analyze over 9,800 retrospectively confirmed sepsis cases and demonstrated AI's transf...

Intraocular lens manufacturers are also aiming to develop next-generation IOLs that offer clearer vision and require minimal post-operative downtime for patients to return to their daily routines. For instance, in June 2025, Johnson & Johnson (US) launched TECHNIS Odyssey next-generation intraocular lens in Europe, Canada, and the Middle East to correct presbyopia. These consistent innovations indicate that the intraocular lens market will remain competitive and progressive during the forecast p...